Andriy Yabluchanskiy to NAD
This is a "connection" page, showing publications Andriy Yabluchanskiy has written about NAD.
Connection Strength
1.125
-
Effects of NAD+ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trial. J Pharmacol Exp Ther. 2025 Jul; 392(7):103607.
Score: 0.897
-
Role of endothelial NAD+ deficiency in age-related vascular dysfunction. Am J Physiol Heart Circ Physiol. 2019 06 01; 316(6):H1253-H1266.
Score: 0.146
-
Insights into the modulation of the interferon response and NAD+ in the context of COVID-19. Int Rev Immunol. 2022; 41(4):464-474.
Score: 0.043
-
Treatment with the poly(ADP-ribose) polymerase inhibitor PJ-34 improves cerebromicrovascular endothelial function, neurovascular coupling responses and cognitive performance in aged mice, supporting the NAD+ depletion hypothesis of neurovascular aging. Geroscience. 2019 10; 41(5):533-542.
Score: 0.038